Dupilumab use in asthma is linked to higher lymphoma risk, especially T and NK cell types, but also shows reduced all-cause ...

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change.

A long-term real-world study of older adults with COPD shows that initiation of tiotropium is linked to a minimal increase in ...

Some asthma therapy appeared to be less effective in Black children living in areas with high levels of nitrogen dioxide (NO2).

a triple-therapy inhaler containing an inhaled corticosteroid (ICS), a long-acting muscarinic antagonist (LAMA), and a long-acting beta-agonist (LABA), was found to offer comparable or incremental ...

Trelegy Ellipta, a triple-therapy inhaler containing an inhaled corticosteroid (ICS), a long-acting muscarinic antagonist (LAMA), and a long-acting beta-agonist (LABA), was found to offer comparable ...

were associated with use of triple therapy compared with inhaled corticosteroids (ICS)/long-acting β2-agonists (LABA) therapy, according to study findings published in the International Journal ...

A medium inhaled corticosteroid dose plus a long-acting ... 6 to 11] years is ‘medium-dose ICS’ or ‘low-dose ICS with LABA,’ which have similar benefits,” Cividini and colleagues added.

With approximately 3 months of routine use, the generic form of the inhaled corticosteroid and long-acting beta-agonist (ICS-LABA) inhaler was shown to carry a similar incidence of first moderate ...

Inhalers with a long-acting muscarinic antagonist and a long-acting beta agonist (LABA) resulted in “better outcomes” than an inhaled corticosteroid plus LABA. This result was sustained in ...